Amphastar Pharma (AMPH) Tops Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2018
November 8, 2018 4:10 PM ESTReports Net Revenues of $75.5 Million for the Three Months Ended September 30, 2018
RANCHO CUCAMONGA, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (Amphastar or the Company) today reported results for the three months ended September 30, 2018.
Third Quarter Highlights
Net revenues of $75.5 million for the third quarterGAAP net income attributable to Amphastar of $2.4 million, or $0.05 per diluted share, for the third quarterAdjusted non-GAAP net income attributable to Amphastar of $5.7 million, or $0.12 per diluted share, for the third quarterDr. Jack Zhang,... More
